在肝细胞癌中鉴定和验证ATP6V1G1调节的酸化蛋白

Yi Zhang1, Liuyi Lu2, Mingxing Chen3

  • 1Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education Nanning, The First Affiliated Hospital of Guangxi Medical University, Guangxi, China.

PloS one
|December 2, 2024
PubMed
概括

空腔ATPase子单元G1 (ATP6V1G1) 影响肝细胞癌 (HCC) 的进展. 这项研究确定了由ATP6V1G1调节的关键酸化蛋白,为肝癌机制提供了洞察力.